We've updated our Privacy Policy to make it clearer how we use your personal data.
We use cookies to provide you with a better experience, read our Cookie Policy
EP23144
Poster Title: Increasing gene editing efficiencies in eukaryotic cell lines by selection of appropriate CRISPR-Cas9 reagents
Submitted on 12 Jun 2015
Author(s): Melissa L. Kelley, Žaklina Strezoska, Elena Maksimova, Hidevaldo Machado, Emily M. Anderson, Maren Mayer, Annaleen Vermeulen, Shawn McClelland, Anja van Brabant Smith
Affiliations: GE Healthcare Dharmacon, Inc.
This poster was presented at ISCT
Poster Views: 4,182
Submitted on 12 Jun 2015
Author(s): Melissa L. Kelley, Žaklina Strezoska, Elena Maksimova, Hidevaldo Machado, Emily M. Anderson, Maren Mayer, Annaleen Vermeulen, Shawn McClelland, Anja van Brabant Smith
Affiliations: GE Healthcare Dharmacon, Inc.
This poster was presented at ISCT
Poster Views: 4,182
Abstract: Genetic engineering of living cells is critical for understanding gene function in normal and diseased states. The CRISPR-Cas9 system is widely utilized because of its ease-of-use compared to other gene editing methods. This system requires a complex of Cas9 protein with tracrRNA and a gene-targeting crRNA to introduce double-strand DNA breaks at specific locations in the genome to disrupt protein translation and knockout gene function. To achieve high gene editing efficiencies, it is essential to choose the best CRISPR-Cas9 reagents for delivery and expression in the cells of interest. Depending on the transfectablity of specific cells, CRISPR components can be delivered using plasmid transfection or lentiviral transduction. Plasmid-expressed Cas9 can be co-transfected with synthetic crRNA and tracrRNA for efficient gene editing in cells amenable to lipid delivery. Cas9 that is packaged into lentiviral particles can be transduced into cells that are refractory to transfection. Lentiviral Cas9 can also be used to generate stable cell lines, which can then be transfected or transduced by synthetic or lentiviral-based CRISPR RNA components; this is particularly useful for screening applications. Importantly, expressing humanized Cas9 from different promoters (e.g., human and mouse CMV and EF1α, PGK, CAG) in different cell types results in varying levels of Cas9 expression and consequently, varying efficiencies of gene editing. In addition, cells transfected or transduced with gene editing reagents can be enriched by antibiotic selection or FACS using reagents in which the Cas9 gene is co-expressed with either an antibiotic resistance marker or a fluorescent protein reporter. This enrichment facilitates the isolation of clonal cells containing the desired mutation. Presented here are data demonstrating improvement of gene editing efficiencies in cells of interest by using the most effective delivery and selection approaches with the optimal CRISPR-Cas9 reagents.Summary: Overview of various CRISPR-Cas9 reagents to provide the highest efficiency of gene editing in your experiments.References: N/A
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Related Posters
Microstructure Analysis of Cr-Mo-V-W High-Entropy Alloys
Daiki Ikeuchi
Multiplex miRNA Profiling for Biomarker Discovery and Verification Studies Using the FirePlex® Platform
M. Tackett, B. Heinrich, I. Diwan, G. Tejada, C. Rafferty, E. Atabakhsh, and D. Pregibon
Platinum™ SuperFi™ DNA Polymerase for the highest success in PCR
Rasa Sukackaitė, Martyna Simutytė, Skaistė Valinskytė, Laurynas Vanagas, Karolis Matjošaitis, Renata Rimšelienė, Remigijus Skirgaila.
Assessment of Radiation Protection Awareness and Knowledge about Common Radiological Examination Doses among Healthcare Workers in Riyadh, Saudi Arabia
Alyousef K, Assiri A, Almutairi S, Aldalham T, Felimban G
DNA-free Platinum Taq DNA polymerase for reliable microbiome studies
Kęstutis Bargaila, Vytautas Budrys, Andrius Krasauskas, Dovilė Lisauskienė, Milda Romeikaitė, Sonata Jurėnaitė-Urbanavičienė,Ramunė Leipuvienė and Juozas Šiurkus